Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells-Reference-Cited by-同舟云学术

Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells

Published:2022-03 Issue: Volume:27 Page:211-226
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Kupryushkin Maxim S.^ORCID,Filatov Anton V.,Mironova Nadezhda L.^ORCID,Patutina Olga A.,Chernikov Ivan V.,Chernolovskaya Elena L.,Zenkova Marina A.^ORCID,Pyshnyi Dmitrii V.^ORCID,Stetsenko Dmitry A.^ORCID,Altman Sidney,Vlassov Valentin V.

Funder

Russian Academy of Sciences Siberian Branch

Russian Foundation for Basic Research

Russian Science Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference77 articles.

1. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide;Zamecnik;Proc. Natl. Acad. Sci. U S A,1978

2. The powerful world of antisense oligonucleotides: from bench to bedside;Quemener;Wiley Interdiscip. Rev. RNA,2020

3. RNA-based therapeutics: from antisense oligonucleotides to miRNAs;Bajan;Cells,2020

4. Promising nucleic acid analogs and mimics: characteristic features and applications of PNA, LNA, and morpholino;Karkare;Appl. Microbiol. Biotechnol.,2006

5. Present and future of antisense therapy for splicing modulation in inherited metabolic disease;Pérez;J. Inherit. Metab. Dis.,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-SARS-CoV-2 gapmer antisense oligonucleotides targeting the main protease region of viral RNA;Antiviral Research;2024-10

2. In Vivo Interactions of Nucleic Acid Nanostructures With Cells;Advanced Materials;2024-09-12

3. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress;Molecular Therapy - Nucleic Acids;2024-09

4. Current status and trends in small nucleic acid drug development: Leading the future;Acta Pharmaceutica Sinica B;2024-09

5. Effect of the Phosphoryl Guanidine Modification in Chimeric DNA–RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro;ACS Chemical Biology;2024-05-30